#PreMarket Primer: Wednesday, October 22: Johnson & Johnson Develops Ebola Vaccine

October 22, 2014 at 08:13 AM EDT

Johnson & Johnson (NYSE: JNJ) has developed a vaccine to fight Ebola and will begin testing the drug on humans in January. If ...